- Contract (Supply)
- 4 year (est.)
- 17 May 2019
- 01 Apr 2020 to 31 Mar 2024 (est.)
To a location in England to be notified to the successful bidder(s) following contract award
- Glaxosmithkline Brentford
The supply of a combined diphtheria, tetanus, pertussis and polio vaccine, deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
Total Quantity or Scope
The supply of diphtheria, tetanus, pertussis and polio vaccine, to be used as part of the national immunisation programme. The Contracting Authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 6 400 000 doses of vaccine. The opportunity is not appropriate for being split into lots however the contract may be awarded to more than one supplier in the manner described in the procurement documents.
|1|| Glaxosmithkline (Brentford) |
The contract has an optional extension for up to an additional 24 months.
- 33651600 - Vaccines
- 33651610 - Diphtheria-pertussis-tetanus vaccines
- 33651670 - Polio vaccines
- Options are available.
The contract(s) is for the benefit of the Contracting Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
- OJEU 229372-2019